MCP Server For Financial Data by EODHD Learn more

Immunovant Inc icon

Immunovant Inc (IMVT NASDAQ) stock market data APIs

$33.5277 0.48(1.4%)
as of November 16, 2026
Try our APIs with free plan!

Immunovant Inc Financial Data Overview

Price chart is built with Anychart

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Prev. Close 33.5277
Open 34.0123
High 34.7813
Low 32.8185
52 wk Range 21.86-45.42
Market Cap 6 887 M
Shares Outstanding 207 M
EPS -0.47
Beta 0.938

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Immunovant Inc (top by weight)

Ticker
100-day Price Change
Weight
CCUS.TO Counterpoint Global CIBC U.S. Small Cap Growth ETF
3.62
GURU.US Global X Guru Index ETF
-6.03 (-8.65%)
1.14
TDNA.US T. Rowe Price Biotech ETF
23.91
1.12
BBC.US Virtus LifeSci Biotech Clinical Trials ETF
-11.67 (-22.22%)
0.80
XBI.US SPDR® S&P Biotech ETF
-11.49 (-7.3%)
0.73
FTKI.US First Trust Small Cap BuyWrite Income ETF
-0.13 (-0.68%)
0.71
SGRW.US Harbor Active Small Cap Growth ETF
-2.43 (-9.19%)
0.60
TMED.US T. Rowe Price Health Care ETF
-0.76 (-2.16%)
0.60
NIXT.US Research Affiliates Deletions ETF
0.89 (2.59%)
0.54
IBBQ.US Invesco Nasdaq Biotechnology ETF
1.42 (4.25%)
0.46

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Immunovant Inc data using free add-ons & libraries


Get Immunovant Inc Fundamental Data

Immunovant Inc logo

Immunovant Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA: -538 016 000
  • Earnings Per Share: -2
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Immunovant Inc Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-09
  • EPS/Forecast: -0.73
GET THE PACKAGE

Get Immunovant Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Immunovant Inc News

Get Immunovant Inc fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.